Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / IRTC - iRhythm gains FDA clearance for ECG software ZEUS system

IRTC - iRhythm gains FDA clearance for ECG software ZEUS system

iRhythm Technologies Inc.
  • iRhythm Technologies ( NASDAQ: IRTC ) said on Friday it had received U.S. Food and Drug Administration clearance for its ECG Utilization Software ZEUS System for the Zio Watch.
  • The ZEUS System combines algorithms with cardiac arrhythmia service.
  • iRhythm plans to launch the ZEUS System for a limited market evaluation in 2023.
  • "iRhythm is focused on redefining the standard of care with earlier insight to predict and prevent disease, and the Zio Watch with ZEUS System provides clinicians a platform that has the potential to meaningfully improve patients’ lives," said Quentin Blackford, CEO of iRhythm.

For further details see:

iRhythm gains FDA clearance for ECG software ZEUS system
Stock Information
Company Name: iRhythm Technologies Inc.
Stock Symbol: IRTC
Market: NASDAQ
Website: irhythmtech.com
Menu
IRTC IRTC Quote IRTC Short IRTC News IRTC Articles IRTC Message Board
Get IRTC Alerts

News, Short Squeeze, Breakout and More Instantly...